snsinsider 님의 블로그

The Alzheimer’s Therapeutics Market was valued at USD 3.78 billion in 2023 and is projected to experience a significant surge, reaching USD 13.42 billion by 2032. The market is expected to grow at a CAGR of 15.14% from 2024 to 2032, fueled by the increasing prevalence of Alzheimer’s disease, advancements in drug development, and rising investments in neurodegenerative research.Key Drivers of Mar..

The Generative AI in Healthcare Market was valued at USD 1.7 billion in 2023 and is projected to experience exponential growth, reaching USD 19.99 billion by 2032 at an impressive CAGR of 31.5% over the forecast period of 2024-2032. The rising adoption of artificial intelligence in medical research, diagnostics, and personalized treatment is revolutionizing the healthcare sector, paving the way ..

The Multiplex Assay Market is on a significant growth trajectory, with its valuation anticipated to climb from USD 3.05 billion in 2023 to USD 8.84 billion by 2032, reflecting a robust CAGR of 11.24% during the forecast period of 2024 to 2032. The demand for advanced diagnostic tools and efficient testing methodologies is driving the widespread adoption of multiplex assay technologies across var..

The Automated Liquid Handling Technologies Market was valued at USD 2.11 billion in 2023 and is expected to grow significantly, reaching USD 5.24 billion by 2032 at a CAGR of 11.18% over the forecast period 2024-2032. This impressive growth is driven by the rising demand for accurate, efficient, and high-throughput solutions in life sciences, biotechnology, and pharmaceutical industries.Key Driv..

The gRNA Market was valued at USD 498.30 million in 2023 and is projected to surge to USD 2,303.70 million by 2032, reflecting a remarkable CAGR of 19.61% over the forecast period from 2024 to 2032. The increasing demand for genome editing technologies, particularly CRISPR-Cas9, is one of the key factors propelling the growth of the gRNA (guide RNA) market across the globe.Key Drivers of GrowthT..

The Pyrogen Testing Market was valued at USD 1.60 billion in 2023 and is projected to achieve a significant milestone of USD 3.17 billion by 2032, growing at an impressive CAGR of 7.93% over the forecast period from 2024 to 2032. This growth is driven by the increasing need for safety and quality control in pharmaceutical and biotechnology products, particularly vaccines, biologics, and injectab..

The Nucleic Acid Isolation and Purification Market was valued at USD 6.60 billion in 2023 and is expected to witness remarkable growth, reaching USD 16.38 billion by 2032, with an impressive CAGR of 11.18% during the forecast period from 2024 to 2032. The increasing demand for high-quality nucleic acid isolation processes is driven by advancements in genomic research, personalized medicine, and ..

The Artificial Intelligence (AI) in Breast Imaging Market was valued at USD 423.9 million in 2023 and is forecasted to experience exponential growth, reaching USD 1886.4 million by 2032 with a compound annual growth rate (CAGR) of 16.1% during the forecast period of 2024-2032. This remarkable growth trajectory is fueled by the increasing adoption of AI-driven solutions to enhance the accuracy, e..

The Cell Therapy Human Raw Materials Market was valued at USD 2.9 billion in 2023 and is expected to witness exponential growth, reaching an estimated USD 18.1 billion by 2032 at a remarkable CAGR of 22.6% over the forecast period from 2024 to 2032. The rising adoption of cell therapy for treating various chronic and rare diseases is a key factor fueling the demand for human raw materials in the..

The Conversational AI in Healthcare Market was valued at USD 10.80 billion in 2023 and is projected to skyrocket to USD 80.50 billion by 2032, registering an impressive CAGR of 25.02% during the forecast period of 2024-2032. The rising adoption of AI-driven solutions in the healthcare sector to improve patient engagement, streamline operations, and enhance decision-making is fueling market growt..